The Pharmaron US team has over a decade of experience successfully supporting cell and gene therapy programs from preclinical through post approval. We understand the complex bioanalytical methods that need to be developed for cell and gene therapy programs and have the specialized expertise to develop qualify and validate robust assays in compliance with FDA/EMA requirements to support your therapeutic programs.
View as PDF: [Whitepaper] Biodistribution and Viral Shedding for Cell and Gene Therapy
View as PDF: Biodistriubution and Shedding
Services
Biodistribution The aim of biodistribution studies is to determine levels of transgene and its product e.g. proteins, where possible
Shedding The aim of shedding studies is to determine the secretion/excretion profile of the virus/vector
Choose an Experienced Partner Utilize our experience to navigate through challenges, such as off-target amplification, variable sample volumes, potential cross-contamination, optimizing low-yield tissue
Capabilities